长期无创通气对COPD严重急性加重与生存的影响:法国全国队列多状态模型研究
该研究基于法国国家医保数据库2015-2019年49 503例开始家庭无创通气的COPD患者,采用多状态模型分析继续与停止无创通气对疾病状态转换的影响。结果显示继续无创通气与死亡风险降低相关,但未减少严重急性加重发生,且从严重急性加重恢复更慢。
要点
- 继续家庭无创通气与COPD患者死亡风险降低相关。
- 继续无创通气未显著减少无急性加重向严重急性加重的转换。
- 继续无创通气与严重急性加重后恢复更慢相关。
核心结论
- 长期家庭无创通气与COPD患者死亡风险降低相关,但与严重急性加重后恢复时间延长相关。
研究设计与样本
- 多状态模型分析,数据来自法国国家医保报销系统数据库2015-2019年。
- 纳入49 503例年龄≥40岁、COPD且至少一次无创通气报销的患者。
- 中位年龄70岁,男性51.2%,前一年中位急性加重次数1次。
主要发现
- 共发生80 361次严重急性加重和18 125例死亡,其中7 805例死亡发生于严重急性加重期间。
- 继续无创通气与严重急性加重后向死亡转换风险降低相关(HR 0.84,95%CI 0.79-0.91)。
- 继续无创通气与无急性加重状态向死亡转换风险降低相关(HR 0.88,95%CI 0.83-0.93)。
- 继续无创通气对无急性加重向严重急性加重转换无显著影响(HR 0.98,95%CI 0.95-1.00)。
- 继续无创通气与严重急性加重向无急性加重转换减慢相关(HR 0.87,95%CI 0.84-0.89)。
临床怎么用
- 长期家庭无创通气可能为COPD患者带来生存获益,可作为指南推荐的证据之一。
- 需注意无创通气未减少严重急性加重发生,且可能延长急性加重后恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Chronic obstructive pulmonary disease (COPD) is the most common indication for domiciliary non-invasive ventilation (NIV), but long-term outcomes data are limited. OBJECTIVE: This multistate model analysis estimated the impact of NIV therapy continuation versus cessation on transitions between three different disease states. METHODS: Model data came from the French national health insurance reimbursement system database for individuals aged ≥40 years with COPD and ≥1 NIV reimbursement in 2015-2019. MEASUREMENT AND MAIN RESULTS: Data from 49 503 patients started on NIV were included (median age 70 years, 51.2% male, median 1 exacerbation in the previous year). There were 80 361 severe exacerbations and 18 125 deaths (including 7805 in severe exacerbation). In multistate models, NIV continuation was associated with a significant reduction in transition to death, from severe exacerbation (HR 0.84, 95% CI 0.79 to 0.91) and without exacerbation (HR 0.88, 95% CI 0.83 to 0.93). NIV continuation versus cessation had no significant effect on transition between without exacerbation to severe exacerbation (HR 0.98, 95% CI 0.95 to 1.00) but was significantly associated with slower transition from severe exacerbation to without exacerbation (HR 0.87, 95% CI 0.84 to 0.89). CONCLUSION: This multistate model analysis found that the long-term use of domiciliary NIV was associated with a lower risk of transitions to death, but was not associated with a reduction in recovery time after severe exacerbation. These data highlight the potential mortality benefits of long-term domiciliary NIV in COPD and can be used as one piece of evidence to support evidence-based guideline recommendations.
引用
- Pépin, Herquelot, Denis, et al. Impact of long-term non-invasive ventilation on severe exacerbations and survival in COPD: a French nationwide cohort study using multistate models. Thorax. 2025. PMID: 40393719. doi:10.1136/thorax-2024-222392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。